Frontera Strategies, a provider of in-office cardiac, pulmonary, vascular and neurological testing services, has entered into a strategic alliance with MGC Diagnostics.
Under the alliance, Frontera has agreed to buy MGC Diagnostics' new cardiopulmonary diagnostic equipment with customized systems to better meet the demanding requirements of its mobile testing procedures.
Frontera Strategies co-founder and partner Richard Baker said the company is pleased to collaborate with MGC Diagnostics to better serve its customers and patients in Oklahoma and Texas, US markets.
"Our goal is to be a thought leader in driving down healthcare costs and we are looking for ways to bring better, more cost efficient diagnostic testing to the marketplace," Baker added.
MGC Diagnostics chief executive officer and president Gregg Lehman said the company is committed to provide new diagnostic equipment to mobile testing services focused at physicians' offices, as well as at traditional healthcare facilities.
"We are pleased to have been chosen by Frontera to assist them in maintaining a leadership role in mobile testing," Lehman added.
